Ophthalmic compositions for treating ocular Demodex using lotilaner formulations
Bobak Robert Azamian, Newport Coast, CA (US); Douglas Michael Ackermann, Reno, NV (US); Shawn D. Hickok, Aliso Viejo, CA (US); and Joseph G. Vehige, Irvine, CA (US)
Assigned to Tarsus Pharmaceuticals, Inc., Irvine, CA (US)
Filed by Tarsus Pharmaceuticals, Inc., Irvine, CA (US)
Filed on Jul. 26, 2022, as Appl. No. 17/873,698.
Application 17/873,698 is a continuation of application No. 17/099,570, filed on Nov. 16, 2020, abandoned.
Application 17/099,570 is a continuation of application No. 16/221,390, filed on Dec. 14, 2018, granted, now 10,835,517, issued on Nov. 17, 2020.
Claims priority of provisional application 62/746,498, filed on Oct. 16, 2018.
Claims priority of provisional application 62/689,787, filed on Jun. 25, 2018.
Claims priority of provisional application 62/626,612, filed on Feb. 5, 2018.
Claims priority of provisional application 62/615,855, filed on Jan. 10, 2018.
Claims priority of provisional application 62/599,213, filed on Dec. 15, 2017.
Prior Publication US 2022/0354830 A1, Nov. 10, 2022